Efficiency Is Half the Product: Lessons From 300 Emergency Ostomy Orders

For 14 years, I've coordinated emergency medical supply deliveries. Not product design. Not clinical care. The operational trenches where a patient's treatment depends on whether a package arrives in hours rather than weeks.

In that time, I've sourced a biosafety cabinet on a weekend when a lab was facing an inspection in 48 hours. I've rush-delivered a CPAP machine to a patient before a flight home from a sleep clinic. And on a Friday afternoon in March 2024, I coordinated an emergency supply of ostomy pouches for a home-care nurse whose patient was two changes away from an ER visit.

Here's the opinion I've formed after roughly 300 such orders:

Efficiency is not a support function to product quality. Efficiency is half of the product itself.

I know that reads like management-speak. It isn't. In chronic care, it has a very specific meaning — and the stakes show up in patient outcomes, not spreadsheets.

A Friday call that made this concrete

The patient was a 74-year-old man managing his colostomy at home. His pharmacy had swapped brands without asking — a cost-saving move — and the substitute pouches didn't seal cleanly. By Thursday night, his skin was raw. He had two pouches left.

The standard mail route for the correct Coloplast pouches? Five business days. The realistic alternative? An emergency room visit. $2,000 to $5,000, plus skin breakdown, plus a real chance the patient would lose confidence in managing his own care.

We called distributors in three states. The third had the right product in stock, 90 minutes away. We paid $120 in courier fees on top of the $60 product cost. For context, a USPS Priority Mail shipment would have cost about $10 (usps.com) — but the timeline didn't allow it. The pouches arrived at the nurse's office at 9:30 the next morning.

The nurse also pulled Coloplast's illustrated guide on how to change an ostomy pouch and used it to walk the patient through a more careful application technique. She told me later the technique mattered as much as the pouch itself.

We ran the numbers before sending the courier. Worst case: the courier fails and we've burned $180 for nothing. Best case: a patient stays home, avoids a $3,000 hospitalization, and keeps trusting the system. The expected value said go. I still remember the knot in my stomach while we waited for the confirmation ping.

Now, let me be clear about what this story is and isn't. The product was fine. The right product had been sitting in inventory all along. The failure was informational and logistical — nobody knew what was correct, what was in stock, and how to get it fast. That's not a quality problem. It's a flow problem. And flow problems are fixable.

What I wish I'd tracked

Honestly, I don't have hard data on the number of patients who end up back in hospital care after one supply-chain failure too many. I wish I'd tracked every cancellation reason, every angry call, every "we'll just switch to someone else." What I can say anecdotally, from 300+ emergency orders, is that a delivery breakdown is the breaking point in maybe 15-20% of cases. The patient doesn't stop needing the product — they stop trusting the system that can't deliver it.

That's where I see the gap for coloplast medical devices. The company puts real effort into clinical education and patient support. The products are well-designed. But knowing a product line well doesn't automatically mean every pharmacy and home-care agency stocks it correctly or reorders on time. The gap between "product exists" and "patient receives product" is exactly where I live.

The truth about lead times

Here's something vendors won't tell you: the "standard lead time" printed on an invoice does not represent how long your order actually needs to take. It's the time the vendor needs to process your order through the normal queue, alongside everyone else's. There's buffer in there. There's batch scheduling. There's a margin of safety that has nothing to do with your urgency.

Most buyers focus on product specs and unit price, and completely miss the leverage they have in how they place orders. The question everyone asks is "what's your lead time?" The question they should ask is "what happens if my patient runs out on a Friday afternoon?"

In 2022, after two failed emergency deliveries cost us a major contract and one very upset nurse, we implemented a rule: we'd only contract with distributors who guarantee a 48-hour emergency escalation path. It added roughly 4-8% to certain product lines. The reduction in crisis-mode, overnight-courier, call-everyone-you-know scrambling paid for itself within two quarters.

Engineering claims are only half the story

Let me give credit where it's due. Coloplast publishes a 5-year mechanical survival rate for many of its intermittent catheters. That's a genuinely impressive engineering metric. Under FTC advertising guidelines (ftc.gov), claims like this must be substantiated — and Coloplast's documentation includes their test data, which I respect.

But here's the uncomfortable follow-up: a 5-year mechanical survival rate means nothing to a patient who can't get the product in the first week.

The engineering promise is "this device will work for you." The logistics promise is "you will have this device when you need it." Both have to hold. In my experience, the logistics promise fails far more often than the engineering promise.

A CPAP machine makes the same point. It's not a Coloplast product, but it behaves identically in the supply chain. I've watched patients fail on CPAP because their replacement mask arrived late or the wrong size. Same machine. Same prescription. Different delivery, different outcome. I've also seen a 24-hour turnaround turn a struggling patient into a confident CPAP user within a month.

That's efficiency acting as a clinical intervention. Not paperwork. Not cost-saving. A patient outcome.

The "quality first" objection — and why it misses the point

I should anticipate the strongest pushback: "You're overvaluing logistics. A poorly designed device doesn't become effective because it arrives quickly."

Agreed. Completely. Clinical design is the foundation — no argument from me. But that objection incorrectly frames quality and efficiency as competitors. They're not. They're sequential. The product must be right, and then the delivery must be right. Both are necessary conditions. Neither alone is sufficient.

My sample is tilted toward North American agencies, so I can't claim a global pattern. But across 300+ orders and a long-running agency relationship, patient satisfaction correlated with delivery reliability almost as strongly as with device usability. That's not a published study — it's a repeated observation that has held up long enough that I've stopped calling it a coincidence.

The second objection is the one I actually respect: "Efficiency initiatives become cost-cutting initiatives." They do. I've watched procurement teams slash buffers and support until the system can't absorb even a routine bump. But that's not efficiency — that's elimination. The efficiency I'm describing removes friction and delay while preserving the redundancies that keep patients safe. Done well, it shows up as fewer emergencies, not more.

Where I've landed

After 14 years and hundreds of emergency orders, here's my bottom line:

The best medical device in the world has a clinical value of zero if it isn't there when a patient needs it. That's not an argument against product quality. It's a reminder that quality includes a delivery dimension.

Coloplast medical products for ostomy care, wound care, continence care — the engineering claims are impressive, but their impact in the real world depends on a supply chain that works on the patient's timeline, not the vendor's.

So when you evaluate medical device suppliers, ask two questions. First: "what's your clinical evidence?" Second: "what happens when my patient needs the product tonight?" The vendors who can't answer both are selling you half a product.

In chronic care, half a product is no product at all.